Indomethacin
Indomethacin is a prescription nonsteroidal anti-inflammatory drug (NSAID) available as 75 mg extended-release oral capsules. It works by inhibiting cyclooxygenase enzymes to reduce pain, inflammation, and fever, commonly used for conditions like arthritis or gout. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Indomethacin is a prescription nonsteroidal anti-inflammatory drug (NSAID) available as 75 mg extended-release oral capsules. It works by inhibiting cyclooxygenase enzymes to reduce pain, inflammation, and fever, commonly used for conditions like arthritis or gout. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Indomethacin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Indomethacin — ANDA 217883 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217883"
}
]
|
| identifier | ANDA217883 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Indomethacin |
